TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Taubert medicin AB
Closing information (x1000 DKK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover | 1,180 | 694 | 146 |
Financial expenses | 1 | 1 | 0 |
Earnings before taxes | 82 | 22 | -53 |
EBITDA | 82 | 22 | -53 |
Total assets | 267 | 193 | 93 |
Current assets | 267 | 193 | 93 |
Current liabilities | 159 | 140 | 71 |
Equity capital | 105 | 41 | 22 |
- share capital | 32 | 33 | 36 |
Employees (average) | 2 | 2 | 1 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency | 39.3% | 21.2% | 23.7% |
Turnover per employee | 590 | 347 | 146 |
Profit as a percentage of turnover | 6.9% | 3.2% | -36.3% |
Return on assets (ROA) | 31.1% | 11.9% | -57.0% |
Current ratio | 167.9% | 137.9% | 131.0% |
Return on equity (ROE) | 78.1% | 53.7% | -240.9% |
Change turnover | 510 | 561 | -51 |
Change turnover % | 76% | 422% | -26% |
Chg. No. of employees | 0 | 1 | 1 |
Chg. No. of employees % | 0% | 100% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.